Compare Neurocrine Biosciences Inc (NBIX) vs Weibo Corp (WB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Weibo Corp — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Weibo Corp trades at $8 (market cap $1.95B). The key difference: Neurocrine Biosciences Inc is far larger — about 8.9× Weibo Corp's market cap, and Weibo Corp pays a 7.63% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | WB | |
|---|---|---|
Market Cap | $17.40B | $1.95B |
Sector | Health | Media |
52-Week High | $180.55 | $12.83 |
52-Week Low | $123.10 | $7.20 |
Enterprise Value | $16.49B | $1.22B |
Dividend Yield | — | 7.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Weibo Corp
Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →
